This FTSE 250 stock fell 15% yesterday. Here’s why I want to buy the dip

Jon Smith talks through the negative news that caused a FTSE 250 stock to fall yesterday but flags up why he thinks there has been an overreaction.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Yesterday (18 September) the PZ Cussons (LSE:PZC) share price dropped by 15%. This is a big move for a FTSE 250 stock that has a market cap of £385m. Yet despite the bad news behind the sharp fall, I’m pretty optimistic about the long-term outlook for the business. Here’s why I’m thinking about buying the stock.

Problems in Africa

Firstly, let’s get the bad news out of the way. The main reason for the drop was the release of the full-year results. It might seem odd for these to come out in September, but the firm operates on a financial year that runs through to the end of May, with results out in September.

In the May-May period, the business saw revenue drop by 19.6% versus the year prior, with profit before tax falling by 39.7%. Even with this drop, it still recorded a profit of £44.7m. Gross debt reduced significantly from £251m at the end of May 2023 to £167m in May 2024.

In the report, the underperformance was blamed on the devaluation of the Nigerian naira. The business earns money in the local currency from operations in the country. Yet it has to sell this and buy British pounds. So the fact that the naira devalued by 57% during the year massively eroded revenue for PZ Cussons.

The impact of this is very telling. If we exclude Africa, like-for-like revenue only fell by 2.6%.

Solutions from here

I understand that the fall in financial performance has spooked some investors. Yet the management team are taking action. They knew that African operations would be a negative not just this year but potentially going forward. Therefore, it has already started conversations around selling it off. The report noted that “the board has received a number of expressions of interest in the Africa business and it is possible that this could lead to a partial or full sale”.

Until this happens, the business is focused on improving US dollar sourcing in Africa, meaning that it doesn’t have to deal as much in local currency. The value of the dollar is much less volatile, meaning that earnings won’t be impacted as much.

When I put this all together, I don’t see the company’s Nigerian operations as being a problem if we fast forward a couple of years down the line. Excluding Africa, things are going well. The UK market is doing much better, with Carex posting a growth year. The initial in-store launch of Childs Farm in the US also bodes well for the coming year for that brand.

Becoming a value play

Let’s also not forget that many of the brands that PZ Cussons sells are consumer staples. This should act to make it a defensive stock which could do well if we get a stock market crash.

The main risk I see is that I might be too early in buying the dip here. The stock is now down 49% over the past year. If pessimism persists, I could be holding an unrealised loss for some time before it has a chance to make a comeback. Even with this, I think it looks like a great value purchase for my portfolio.

Jon Smith has no position in any of the shares mentioned. The Motley Fool UK has recommended PZ Cussons. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Growth Shares

Growth Shares

2 growth shares that I think are very exposed to a 2026 stock market crash

Despite not seeing any immediate signs of a stock market crash, Jon Smith points out a couple of stocks he's…

Read more »

Investing Articles

Prediction: the BT share price could reach as high as £3 in 2026

Analysts have a wide range of targets on the BT share price, as the telecoms giant has ambitious cash flow…

Read more »

Investing Articles

Here’s my top FTSE 250 pick for 2026

UK investors looking for under-the-radar opportunities should check out the FTSE 250. And 2026 could be an exciting year for…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

Should I sell my Scottish Mortgage shares in 2026?

After a strong run for Scottish Mortgage shares, our writer wonders if he should offload them to bank profits in…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

These fabulous 5 UK stocks doubled in 2025 – can they do it again next year?

These five UK stocks have more than doubled investors' money as the FTSE 100 surges. Harvey Jones wonders if they…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Can this airline stock beat the FTSE 100 again in 2026?

After outperforming the FTSE 100 in 2025, International Consolidated Airlines Group has a promising plan to make its business more…

Read more »

Investing Articles

5 growth stocks on Dr James Fox’s watchlist for 2026

Dr James Fox believes these UK and US growth stocks are worth considering as he looks to outperform the stock…

Read more »

Investing Articles

With a 7% dividend yield, this could be one of the stock market’s best growth plays

Yes, that's right. This company has one of the largest dividends on the UK stock market, but Dr James Fox…

Read more »